Your new post is loading...
Multiple Sclerosis (MS) is a condition causes the immune system to attack the lining of nerves in the brain and spinal cord. Most patients are diagnosed in their 20s and 30s.
One existing treatment is for the immune system to be suppressed with chemotherapy and then stem cells are introduced to the patient's bloodstream - this procedure is known as an autologous haematopoietic stem cell transplant (HSCT).
In the new study, Canadian researchers went further - not just suppressing the immune system, but destroying it altogether. It is then rebuilt with stem cells harvested from the patient's own blood which are at such an early stage, they have not developed the flaws that trigger MS.
The authors said that among the survivors, over a period of up to 13 years, there were no relapses and no new detectable disease activity.
A scientific study conducted in Canada suggests that aggressive chemotherapy followed by a stem cell transplant can halt the progression of multiple sclerosis (MS.